Erlizumab, CAS 211323-03-4

Product Description: Erlizumab is a CHO-expressed humanized antibody that targets Integrin b2/ITGB2/CD18. Erlizumab is equipped with a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for Erlizumab can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

Applications: COVID-19-immunoregulation

Formula: N/A

CAS Number: 211323-03-4

Molecular Weight: N/A

Research Area: Inflammation/Immunology

Target: Others

• SKU: MEXHY-P99946-1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99946-1
• Package Unit: 1 mg
• Quantity Unit: STK
• Conjugate: Unconjugated